Mfd. by :- Alexion Pharmaceuticals (Fulfilled By : Magicine Pharma)
Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.
Soliris is a formulation of Eculizumab, a humanized monoclonal antibody. This medicine is used in the treatment of patients diagnosed with myasthenia gravis. This disease is a long-term neuromuscular condition. Eculizumab is also used in the prevention of red blood cell breakdown. It is indicated to patients weighing above 5 kilograms (11 pounds) to treat various blood disorders. Soliris (Eculizumab) is available in the strength of 300mg as injections for intravenous (IV) use only.
Soliris comprises Eculizumab as its active salt. It is a monoclonal antibody that inhibits the cleavage of complement protein C5 into C5a and C5b, as well as the development of the terminal complement complex C5b-9. Complement-mediated intravascular hemolysis in paroxysmal nocturnal hemoglobinuria, complement-mediated microangiopathy in atypical hemolytic uremic syndrome, and immune-mediated inflammation and central nervous system damage in neuromyelitis optica spectrum disorder are all prevented by inhibiting this complex.
The following are some interactions of Soliris (Eculizumab) injection with other drugs and diseases. You may require dose modifications.
Soliris (Eculizumab) injection may interact with alcoholic drinks. This may lead to severe effects. Thus, it’s advisable to avoid alcohol consumption.
Soliris (Eculizumab) injection is not indicated for use in the following conditions.
The following are some side effects of Soliris (Eculizumab) injection. Contact your doctor if these events occur for too long or become severe.
Soliris (Eculizumab) injection is not indicated for self-use. You can’t take this drug on your own. Your doctor will administer Soliris injection as per a fixed strength. It must be given intravenously (into a vein) after dilution.
If you skip a dose of Soliris (Eculizumab) injection, you must ask your doctor about the best ways to cope with it. Your therapy may require rescheduling.
If you overdose on Soliris (Eculizumab) injection, you may experience symptoms like dizziness, fainting, and shortness of breath. Other symptoms may also arise. Consult your doctor immediately.
Ans- Soliris (Eculizumab) is used in the treatment of patients diagnosed with myasthenia gravis. It is also used in the prevention of red blood cell breakdown.
Ans- Soliris (Eculizumab) injection is not indicated for self-use. You can’t take this drug on your own. Your doctor will administer Soliris injection as per a fixed strength.
Ans- The side effects of Soliris (Eculizumab) injection are vomiting, headache, hives, loss of voice, trouble sleeping, loss of appetite, ear congestion, chills, cough, diarrhea, pounding in the ears, pain in the arms, pale skin, etc.
Ans- If you overdose on Soliris (Eculizumab) injection, you may experience symptoms like dizziness, fainting, and shortness of breath. Other symptoms may also arise.
Ans- During pregnancy, the use of Soliris (Eculizumab) injection may be unsafe. Consult your doctor to know the risks and benefits of this drug.
Ans- During breastfeeding, the use of Soliris (Eculizumab) injection may be unsafe. Either discontinue breastfeeding or know the benefits and risks of this drug.
Ans- Soliris (Eculizumab) is available in the form of injections.
Ans- Soliris (Eculizumab) is available in the strength of 300mg.
Ans- Soliris (Eculizumab) injection may interact with alcoholic drinks. This may lead to severe effects. Thus, it’s advisable to avoid alcohol consumption.
Ans- Store Soliris (Eculizumab) at 2º-8º C.
Fill the Form
Talk to Executive
Get Tracking
Get Medicines Delivered
